Skip to main content

Research Repository

Advanced Search

Treatment of intracerebral haemorrhage with tranexamic acid: a review of current evidence and ongoing trials

Law, Zhe Kang; Meretoja, Atte; Engelter, Stefan T.; Christensen, Hanne; Muresan, Eugenia-Maria; Glad, Solveig B.; Liu, Liping; Bath, Philip M.W.; Sprigg, Nikola

Treatment of intracerebral haemorrhage with tranexamic acid: a review of current evidence and ongoing trials Thumbnail


Authors

Zhe Kang Law

Atte Meretoja

Stefan T. Engelter

Hanne Christensen

Eugenia-Maria Muresan

Solveig B. Glad

Liping Liu

Philip M.W. Bath

NIKOLA SPRIGG nikola.sprigg@nottingham.ac.uk
Professor of Stroke Medicine



Abstract

Purpose
Haematoma expansion is a devastating complication of intracerebral haemorrhage with no established treatment. Tranexamic acid had been an effective haemostatic agent in reducing post-operative and traumatic bleeding. We review current evidence examining the efficacy of tranexamic acid in improving clinical outcome after intracerebral haemorrhage.
Method
We searched MEDLINE, EMBASE, CENTRAL and clinical trial registers for studies using search strategies incorporating the terms “intracerebral haemorrhage”, “tranexamic acid” and “antifibrinolytic”. Authors of ongoing clinical trials were contacted for further details.
Findings
We screened 268 publications and retrieved 17 articles after screening. Unpublished information from three ongoing clinical trials was obtained. We found five completed studies. Of these, two randomised controlled trials comparing intravenous tranexamic acid to placebo (n=54) reported no significant difference in death or dependency. Three observational studies (n=281) suggested less haematoma growth with rapid tranexamic acid infusion. There are six ongoing randomised controlled trials (n=3089) with different clinical exclusions, imaging selection criteria (spot sign and haematoma volume), time window for recruitment and dosing of tranexamic acid.
Discussion
Despite their heterogeneity, the ongoing trials will provide key evidence on the effects of tranexamic acid on intracerebral haemorrhage. There are uncertainties of whether patients with negative spot sign, large haematoma, intraventricular haemorrhage, or poor Glasgow Coma Scale should be recruited. The time window for optimal effect of haemostatic therapy in intracerebral haemorrhage is yet to be established.
Conclusion
Tranexamic acid is a promising haemostatic agent for intracerebral haemorrhage. We await the results of the trials before definite conclusions can be drawn.

Citation

Law, Z. K., Meretoja, A., Engelter, S. T., Christensen, H., Muresan, E.-M., Glad, S. B., …Sprigg, N. (in press). Treatment of intracerebral haemorrhage with tranexamic acid: a review of current evidence and ongoing trials. European Stroke Journal, https://doi.org/10.1177/2396987316676610

Journal Article Type Article
Acceptance Date Sep 29, 2016
Online Publication Date Oct 25, 2016
Deposit Date Nov 24, 2016
Publicly Available Date Nov 24, 2016
Journal European Stroke Journal
Electronic ISSN 2396-9873
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1177/2396987316676610
Keywords tranexamic acid, intracerebral haemorrhage, anti-fibrinolytic, haemostatic agent, haematoma expansion, spot sign, clinical trials, systematic reviews
Public URL https://nottingham-repository.worktribe.com/output/821819
Publisher URL http://eso.sagepub.com/content/early/2016/10/25/2396987316676610
Contract Date Nov 24, 2016

Files






Downloadable Citations